Compare Johnson & Johnson (JNJ) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Upwork Inc — how do they compare? Johnson & Johnson trades at $250.39 (market cap $598.96B), while Upwork Inc trades at $9.3 (market cap $1.15B). The key difference: Johnson & Johnson is far larger — about 520.8× Upwork Inc's market cap, and Johnson & Johnson pays a 2.15% dividend while Upwork Inc pays none. Which is the better fit depends on your goals.
| JNJ | UPWK | |
|---|---|---|
Market Cap | $598.96B | $1.15B |
Volume | 6,156,228 | — |
Sector | Health | Industrials |
52-Week High | $267.24 | $22.11 |
52-Week Low | $164.36 | $7.84 |
Enterprise Value | $631.90B | $952.17M |
Dividend Yield | 2.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
UPWK trades at $9.33, up 2.98% today, with a neutral technical signal and mixed earnings history including recent EPS misses. Revenue grew to $787.78M in 2025 with strong profitability margins (net margin 13.81%), but cash flow turned negative. Analyst consensus is a Buy with a $10.67 target, though legal investigations and competitive pressures pose headwinds.
The stock offers value with low P/E (11.19) and EV/EBITDA (5.96), but risks include ongoing fraud probes and gig economy volatility. Upside depends on execution amid AI integration initiatives, while downside is cushioned by solid balance sheet liquidity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
